ACP5 and cancer: The observed suppression was mediated by c-Src, since inhibition of miR-222-3p elevated expression of c-Src and a partial silencing of c-Src reduced expression of the osteoclast marker genes such as TRAP and cathepsin K. The role of miRNAs has not been fully understood in bone-related metabolic diseases and cancer.